Image

Leveraging Parents and Peers to Increase Recovery Capital in Emerging Adults

Supporting young adults' recovery by involving family and friends.

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

Emerging adults (EAs), aged 18-26, often misuse more than one drug (called poly-substance use or poly-SU). This study tests a new service called Launch to help them. Launch combines support from both a parent and peers. The parent uses a program called contingency management, which gives rewards for positive behavior, to support their EA child. Peer recovery support services (PRSS) are also offered to help EAs. The study will include 48 families, and each will be assigned to one of three groups: (1) parents receive virtual coaching, (2) EAs receive in-person or virtual peer support, or (3) both parents and EAs receive their respective supports.

  • Participants: EAs aged 18-26 with a supportive parent, peer workers, parent coaches, and payors/providers.
  • Participation involves virtual and/or in-person sessions.
  • Goal: Assess if Launch is doable and liked by participants.

If you are an EA with a supportive parent, a peer worker, a parent coach, or work with recovery services, you might be eligible. However, EAs needing intensive treatment like hospital care are not eligible.

Print
Study details
    Polysubstance Drug Use (Indiscriminate Drug Use)

NCT06414993

Chestnut Health Systems

14 March 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.